PEOPLE - Infu-Tech (US) makes appointments:
This article was originally published in Clinica
Infu-Tech, a US provider of infusion therapy and other medical products, has made the following appointments: Michael Elfenbein, formerly vice-chairman of Hemo Biologics International, becomes chief operating officer; Paul Parrish from National Medical Care becomes vice-president of field operations; and Apria Healthcare's Sal Bastardi becomes vice-president of corporate operations.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.